Allogene Therapeutics, Inc. (ALLO)
1.31
-0.07
(-5.07%)
USD |
NASDAQ |
Dec 30, 16:00
1.30
-0.01
(-0.76%)
After-Hours: 07:27
Allogene Therapeutics Market Cap: 294.40M for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.784B |
| AIM ImmunoTech, Inc. | 0.9629M |
| Perspective Therapeutics, Inc. | 203.69M |
| Protalix Biotherapeutics, Inc. | 139.93M |
| Armata Pharmaceuticals, Inc. | 226.70M |
Market Cap Related Metrics
| Price to Book Value | 0.9336 |
| Price | 1.31 |
| Earnings Yield | -74.89% |